New targets and non-cytotoxics in ovarian cancer.
Eisenhauer
E A
EA
NCIC Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017978:Receptors, Growth Factor / Q000037:antagonists & inhibitors*
D020533:Angiogenesis Inhibitors; D017978:Receptors, Growth Factor